Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
Top Cited Papers
- 1 March 2002
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 8 (3) , 282-288
- https://doi.org/10.1038/nm0302-282
Abstract
The tumor suppressor p53 inhibits tumor growth primarily through its ability to induce apoptosis. Mutations in p53 occur in at least 50% of human tumors. We hypothesized that reactivation of mutant p53 in such tumors should trigger massive apoptosis and eliminate the tumor cells. To test this, we screened a library of low-molecular-weight compounds in order to identify compounds that can restore wild-type function to mutant p53. We found one compound capable of inducing apoptosis in human tumor cells through restoration of the transcriptional transactivation function to mutant p53. This molecule, named PRIMA-1, restored sequence-specific DNA binding and the active conformation to mutant p53 proteins in vitro and in living cells. PRIMA-1 rescued both DNA contact and structural p53 mutants. In vivo studies in mice revealed an antitumor effect with no apparent toxicity. This molecule may serve as a lead compound for the development of anticancer drugs targeting mutant p53.Keywords
This publication has 29 references indexed in Scilit:
- Immunolocalization of Human p14ARF to the Granular Component of the Interphase NucleolusExperimental Cell Research, 2000
- Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapyOncogene, 2000
- Pharmacological Rescue of Mutant p53 Conformation and FunctionScience, 1999
- p53-Induced Apoptosis as a Safeguard against CancerBiochemical and Biophysical Research Communications, 1999
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- Regulation of Mutant p53 Temperature-sensitive DNA BindingPublished by Elsevier ,1996
- Allosteric Regulation of the Thermostability and DNA Binding Activity of Human p53 by Specific Interacting ProteinsPublished by Elsevier ,1996
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes & Development, 1994